Announcement • May 19
Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line Kraig Biocraft Laboratories, Inc. announced a biotechnology breakthrough with the successful creation of an immortalized silk gland cell line. The Company believes this technology could form the foundation for a next-generation biotechnology platform with potential applications in biopharmaceutical manufacturing, therapeutic peptides, biologically active proteins, and advanced biomaterials. This breakthrough significantly expands the potential commercial reach of the Company's core technologies beyond recombinant spider silk fibers and textiles. As part of the scientific advancement announced, the Company's research team successfully isolated and established immortalized silk gland cells that demonstrate strong proliferative capacity, stable serial passaging, and robust long-term viability in vitro. Early testing has shown exceptionally strong recombinant protein expression and production capabilities, positioning the platform as a promising candidate for scalable industrial bioprocessing and recombinant protein manufacturing. The immortalized cell line has also demonstrated promising adaptability toward suspension culture systems, a critical requirement for large-scale industrial manufacturing and modern bioprocessing. This capability could allow the platform to integrate with conventional bioprocessing infrastructure and support more efficient, scalable, and cost-effective production systems. The Company believes the unique biology of silkworm silk gland cells may provide important advantages for the production of specialized proteins and other biologically active compounds. Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk. Announcement • Apr 30
Kraig Biocraft Laboratories, Inc. Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk Kraig Biocraft Laboratories, Inc. announced significant progress in the processing of its recently produced recombinant spider silk cocoons into reeled silk. Earlier this month, Kraig Labs announced that it had successfully produced nearly 1.8 metric tons of recombinant spider silk cocoons, marking a historic milestone in the commercialization of spider silk. The Company confirmed that the conversion of those cocoons into reeled silk fiber is now approximately 50% complete. The silk currently being processed represents the volume of recombinant spider silk ever produced by Kraig Labs and is now moving through the next critical stage of commercialization. Once complete, this processing cycle will yield a substantial inventory of spider silk fiber ready to support ongoing product development initiatives and future commercial opportunities. The accompanying image in this release highlights only a portion of the reeled silk already produced from this record-setting production run. As processing continues, the Company expects total silk output to increase significantly as the remaining cocoons are converted into reeled silk. This milestone represents another breakthrough in the Company’s strategy to establish the world's first and only reliable, commercially scalable, and cost-effective supply chain for spider silk, nature's super material. Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk. Announcement • Apr 21
Kraig Biocraft Laboratories Advances Record Production and Begins Processing Recombinant Spider Silk Cocoons Kraig Biocraft Laboratories, Inc. had begun processing nearly 1.8 metric tons of recombinant spider silk cocoons into finished reeled silk. In early April, the Company announced that it had exceeded 1.3 metric tons of cocoon production in March, setting a new production record. Since that announcement, Kraig Labs is now confirming that it produced an additional half ton of cocoons (approximately) that were not included in the March report. This brings the Company's total available cocoon inventory to nearly 1.8 metric tons. Kraig Labs has now initiated the reeling process, converting this inventory into finished reeled silk. This work is currently underway at one of the Company's production partners and is expected to be completed by the end of the month. Upon completion of this processing phase, Kraig Labs expects to hold the inventory of recombinant spider silk in its history. The finished reeled silk will shortly be available for processing, including twisting into yarns and integration into textile and technical material applications. Kraig Labs plans to make these materials available to targeted markets, including luxury fashion, performance textiles, and industrial applications. Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk. 
